| Company/Division name | Empire Bio Diagnostics Corp |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2020 |
| Year reshoring implemented or to be implemented: | 2020 |
| Domestically, the work will be done: | Both |
| Capital investment ($): | 2 |
| City reshored to: | Long Island, Syracuse |
| State(s) reshored to: | NY |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | Viral Transport Medium Kits, plastic inj. molding |
| What non-domestic negative factors made offshoring less attractive? | Loss of control, Travel cost/time |
| What domestic positive factors made reshoring more attractive? | Customer responsiveness improvement, Government Incentives, Higher productivity, Infrastructure, Image/brand, Impact on domestic economy, Lead time/Time to market, Proximity to customers/market, Under-utilized capacity, Covid-19 |
| Government Incentive dollar amount: | $500,000 |
